We are pleased to announce a £11.5 million investment to fund two new packaging lines at our Hatfield production plant in Hertfordshire. Following a succession of approvals and reimbursements across the world for one of our compounds, we are now expanding facilities to triple output within the next three years, targeting a four-fold increase by 2025 to meet global demand.
The expansion comes from the transformation of manufacturing operations. Over the last 13 years we have gone from only supplying medicines in Europe to supplying them all over the world. The Hatfield plant, which serves as a global supply centre for our medicines, is now supplying 73 countries worldwide and by expanding global packaging capabilities, with blistering and serialisation as well as high containment systems as standard, we will be able to offer full service support for a larger global supply of products and ensure more patients are benefiting from access to our medicines.
As part of the investment two local firms have been appointed, based in St. Albans and Rickmansworth, for the design and fit out of the new facilities due to be completed in July 2021.